Home > Cashflow Statement > BIOCON

BIOCON
Cash Flow from Financing Activities

    Back to Cashflow Statement
BIOCON is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Top Undervalued Mid Cap Stocks
AD     Remove this Ad

BIOCON Last 5 Year Cash Flow from Financing Activities History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Cash Flow from Financing Activities ₹-1,854 Cr₹-2,333 Cr₹13,049 Cr₹242 Cr₹2,564 Cr

What is the latest Cash Flow from Financing Activities ratio of BIOCON ?

The latest Cash Flow from Financing Activities ratio of BIOCON is ₹-1,854 Cr based on Mar2025 Consolidated results.
Year Cash Flow from Financing Activities
Mar2025₹-1,854 Cr
Mar2024₹-2,333 Cr
Mar2023₹13,049 Cr
Mar2022₹242 Cr
Mar2021₹2,564 Cr

How is Cash Flow from Financing Activities of BIOCON Trending?

Years Cash Flow from Financing Activities % Change
Mar2025 ₹-1,854 Cr
Negative
Mar2024 ₹-2,333 Cr
Negative
Mar2023 ₹13,049 Cr
5,289.80
Mar2022 ₹242 Cr
-90.56
Mar2021 ₹2,564 Cr -

Compare Cash Flow from Financing Activities of peers of BIOCON

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
BIOCON ₹57,144.8 Cr -7.2% -9.5% 4.8% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹406,603.0 Cr -5.6% -2.5% -1.7% Stock Analytics
DIVIS LABORATORIES ₹155,485.0 Cr -2.6% -8.7% 1.2% Stock Analytics
TORRENT PHARMACEUTICALS ₹135,009.0 Cr -7.2% -8% 27.6% Stock Analytics
DR REDDYS LABORATORIES ₹101,628.0 Cr -6.5% -5.4% 3.9% Stock Analytics
CIPLA ₹96,400.8 Cr -4.1% -11.5% -19% Stock Analytics


BIOCON Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
BIOCON

-7.2%

-9.5%

4.8%

SENSEX

-1%

-10.9%

-6%


You may also like the below Video Courses